Utilization of health care resources for low-risk patients with acute, nonvariceal upper GI hemorrhage: an historical cohort study

Gastrointest Endosc. 2002 Mar;55(3):321-7. doi: 10.1067/mge.2002.121880.

Abstract

Background: Adults hospitalized with acute, nonvariceal upper GI hemorrhage can be accurately stratified according to their risk of subsequent adverse outcomes by using the Rockall score. Low-risk patients (Rockall score less-than-or-equal 2) may be candidates for early discharge.

Methods: Cases were identified with ICD-9-CM codes for calendar years 1997 and 1998. Medical record data to determine patient Rockall risk score, health care resource utilization, and adverse outcomes were abstracted with standardized forms.

Results: Fifty-three of 175 (30%) cases had Rockall scores < or =2. As predicted, those patients with Rockall scores < or =2 had a low risk of adverse outcomes with only 2 of 53 (4%) meeting criteria for recurrent bleeding as defined by the "Rebleed" variable, and no mortality. These low-risk patients had a mean hospital stay of 2.6 plus minus 2.1 days; 49% were admitted to an intermediate or intensive care unit bed and 57% were given H2 receptor antagonists intravenously.

Conclusions: The proportion of patients admitted with acute, nonvariceal, upper GI hemorrhage with Rockall Scores < or =2 was substantial. Adverse outcomes were rare. In contrast, the level of health care resource utilization appeared high. The Rockall score has potential as a clinically based concurrent decision rule to improve the quality of care by finding those patients less likely to require intensive health care services.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cohort Studies
  • Endoscopy, Digestive System
  • Esophagitis / complications
  • Female
  • Gastrointestinal Hemorrhage / classification*
  • Gastrointestinal Hemorrhage / epidemiology
  • Gastrointestinal Hemorrhage / etiology
  • Health Resources / statistics & numerical data*
  • Histamine H2 Antagonists / administration & dosage
  • Histamine H2 Antagonists / therapeutic use
  • Humans
  • Intensive Care Units / statistics & numerical data
  • Length of Stay / statistics & numerical data*
  • Male
  • Middle Aged
  • Risk Assessment
  • Severity of Illness Index
  • Stomach Ulcer / complications

Substances

  • Histamine H2 Antagonists